(Q33379060)

26 July 2017

title

Five donors-one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors (English)

1 reference

26 July 2017

6

Hermann Einsele

1 reference

26 July 2017

Björn Schöttker

1

1 reference

26 July 2017

Tobias Feuchtinger

2

1 reference

26 July 2017

Michael Schumm

3

1 reference

26 July 2017

Erdwine Klinker

4

1 reference

26 July 2017

Rupert Handgretinger

5

1 reference

26 July 2017

Gernot Stuhler

7

1 reference

26 July 2017

publication date

25 March 2008

1 reference

26 July 2017

number of pages

5

1 reference

Nature Clinical Practice Oncology

inferred from page(s)

published in

1 reference

26 July 2017

volume

5

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

291-295

1 reference

Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1105

7 January 2021

Identifiers

DOI

10.1038/NCPONC1105

1 reference

26 July 2017

1 reference